🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Cohen & Steers Inc. reaches 52-week high, hitting $86.13

Published 07/25/2024, 01:04 PM
CNS
-

Cohen & Steers Inc. (CNS) has reached a new 52-week high, with its stock price soaring to $86.13. This milestone reflects the company's strong performance over the past year, which has seen a significant uptick in its market value. The 52-week high is a testament to the company's resilience and strategic growth initiatives, which have been well-received by investors. Over the past year, Cohen & Steers Inc. has seen a substantial increase in its value, with a 1-year change of 28.07%. This impressive growth rate underscores the company's robust financial health and its ability to deliver consistent returns to its shareholders.

In other recent news, Cohen & Steers has reported a slight decrease in earnings per share and revenue for Q2 2024, due to underperformance in equity-oriented asset classes and a slight drop in assets under management. The company's earnings per share for the quarter were $0.68, down from $0.70 in the same quarter of the previous year, and revenue reached $122 million. The company's assets under management declined by 1% to $80.7 billion. Despite these challenges, Cohen & Steers announced several growth initiatives, including the launch of the Future of Energy Fund and plans to introduce active ETFs. Furthermore, the company has made leadership changes, appointing Raja Dakkuri as CFO and Dan Noonan as Head of Wealth Distribution. These are among the recent developments at Cohen & Steers, as the company navigates market shifts and high interest rates in the closed-end fund market.

InvestingPro Insights

As Cohen & Steers Inc. (CNS) celebrates its new 52-week high, the InvestingPro platform provides deeper insights into the company's financial metrics and stock performance. With a market capitalization of $4.33 billion and a P/E ratio standing at 32.96, the company is trading at a high earnings multiple, which indicates investor confidence in its future earnings potential. Notably, CNS has maintained its dividend payments for 21 consecutive years, showcasing a commitment to shareholder returns, and currently offers a dividend yield of 2.91%. This is particularly attractive for income-focused investors.

In the short term, the stock has shown a strong return over the last month with a 13.97% increase, and over the last three months, it has climbed 16.88%. Investors looking for additional InvestingPro Tips, such as the company's Price / Book multiple of 11.38 or the latest analyst predictions, can find further exclusive insights on the InvestingPro platform. Moreover, there are 7 additional InvestingPro Tips available for CNS, which can be accessed using the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription. These tips could provide valuable context for investors considering whether to buy, hold, or sell CNS shares as they navigate the market's volatility and the company's trading near its 52-week high.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.